IPNews® – Moderna has recently taken issue with a trademark application filed for COVID MVAX filed by a competitor.

The COVID MVAX trademark application was filed by GlaxoSmithKline. Moderna is taking the position that the trademark will limit its ability to adequately describe its own Covid vaccine. To continue reading, click: COVID Trademark Fight Erupts Between Pharma Companies